Medistim ASA (OSL:MEDI)
260.00
+8.00 (3.17%)
Oct 24, 2025, 4:25 PM CET
Medistim ASA Market Cap
Medistim ASA has a market cap or net worth of 4.75 billion as of October 24, 2025. Its market cap has increased by 54.41% in one year.
Market Cap
4.75B
Enterprise Value
4.61B
Revenue
662.18M
Ranking
n/a
PE Ratio
33.36
Stock Price
260.00
Market Cap Chart
Since May 28, 2004, Medistim ASA's market cap has increased from 40.53M to 4.75B, an increase of 11,623.16%. That is a compound annual growth rate of 24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 4.60B | 68.18% |
| Dec 30, 2024 | 2.74B | -30.01% |
| Dec 29, 2023 | 3.91B | -7.22% |
| Dec 30, 2022 | 4.22B | -37.01% |
| Dec 30, 2021 | 6.69B | 47.10% |
| Dec 30, 2020 | 4.55B | 30.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.83B |
| ArcticZymes Technologies ASA | 1.50B |
| Photocure ASA | 1.36B |
| Thor Medical ASA | 1.24B |
| Vistin Pharma ASA | 962.28M |
| Omda AS | 947.45M |
| Gentian Diagnostics ASA | 820.47M |
| Nykode Therapeutics AS | 780.45M |